Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Allergy
|
July 29, 2023
Patients with naproxen-induced liver injury display T-cell memory responses toward an oxidative (S)-O-desmethyl naproxen metabolite but not the acyl glucuronide
Paul Thomson, Nik Fragkas, Laila M Kafu, et al.
Regulatory Toxicology and Pharmacology : RTP
|
January 2, 2021
The use of emerging safety biomarkers in nonclinical and clinical safety assessment - The current and future state: An IQ DruSafe industry survey
Tanja S Zabka, John Burkhardt, William J Reagan, et al.
Scientific Reports
|
November 18, 2016
Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
Noria Segueni, Elaine Tritto, Marie-Laure Bourigault, et al.
Molecular Therapy. Advances
|
May 15, 2026
Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeys
Maria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Molecular Therapy. Methods & Clinical Development
|
November 10, 2025
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeys
Maria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 31, 2016
Rat Urinary Osteopontin and Neutrophil Gelatinase-Associated Lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury
Jonathan A Phillips, Daniel J Holder, Daniela Ennulat, et al.
Toxicology
|
November 17, 2024
The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
Laura Micheli, David Balayssac, Jérôme Busserolles, et al.
Science Translational Medicine
|
February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
Anette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Science Translational Medicine
|
February 1, 2023
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Allergy
|
July 29, 2023
Patients with naproxen-induced liver injury display T-cell memory responses toward an oxidative (S)-O-desmethyl naproxen metabolite but not the acyl glucuronide
Paul Thomson, Nik Fragkas, Laila M Kafu, et al.
Regulatory Toxicology and Pharmacology : RTP
|
January 2, 2021
The use of emerging safety biomarkers in nonclinical and clinical safety assessment - The current and future state: An IQ DruSafe industry survey
Tanja S Zabka, John Burkhardt, William J Reagan, et al.
Scientific Reports
|
November 18, 2016
Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
Noria Segueni, Elaine Tritto, Marie-Laure Bourigault, et al.
Molecular Therapy. Advances
|
May 15, 2026
Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeys
Maria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Molecular Therapy. Methods & Clinical Development
|
November 10, 2025
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeys
Maria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 31, 2016
Rat Urinary Osteopontin and Neutrophil Gelatinase-Associated Lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury
Jonathan A Phillips, Daniel J Holder, Daniela Ennulat, et al.
Toxicology
|
November 17, 2024
The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
Laura Micheli, David Balayssac, Jérôme Busserolles, et al.
Science Translational Medicine
|
February 1, 2023
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
Anette C Karle, Matthias B Wrobel, Stephan Koepke, et al.
Science Translational Medicine
|
February 1, 2023
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
Jeffrey D Kearns, Paul Wassmann, Ufuk Olgac, et al.
Page
of 3